American Society of Hematology

Figure 2.

Outline of a risk-based management approach to anthracycline cardiomyopathy. For more on the outline, see Lyon et al,15 Pudil et al,17 and Öztürk et al.19 cTn, cardiac troponin, ECG, electrocardiogram, HTN, hypertension, NPs, natriuretic peptides.

Outline of a risk-based management approach to anthracycline cardiomyopathy. For more on the outline, see Lyon et al,¹⁵ Pudil et al,¹⁷ and Öztürk et al.¹⁹ cTn, cardiac troponin, ECG, electrocardiogram, HTN, hypertension, NPs, natriuretic peptides.

This Feature Is Available To Subscribers Only